{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:36:23Z","timestamp":1762497383889,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":104,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.4158\/accr-2019-0551","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T19:44:17Z","timestamp":1592941457000},"page":"e247-e251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eradication of Papillary Thyroid Carcinoma In A Patient Receiving Pemetrexed and Bevacizumab"],"prefix":"10.1016","volume":"6","author":[{"given":"John Dylan","family":"Pate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Bonucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/ACCR-2019-0551_bb0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/annonc\/mdx754","article-title":"OV21\/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer","volume":"29","author":"Provencher","year":"2018","journal-title":"Ann Oncol"},{"key":"10.4158\/ACCR-2019-0551_bb0015","series-title":"Jatin Shah\u2019s Head and Neck Surgery and Oncology.","first-page":"471","article-title":"Thyroid and Parathyroid Glands","author":"Shah","year":"2012"},{"key":"10.4158\/ACCR-2019-0551_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.4158\/ACCR-2019-0551_bb0025","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1210\/er.2019-00085","article-title":"Contemporary debates in adult papillary thyroid cancer management","volume":"40","author":"McLeod","year":"2019","journal-title":"Endocr Rev"},{"key":"10.4158\/ACCR-2019-0551_bb0030","unstructured":"DynaMed.Papillary Thyroid Cancer. Available at: https:\/\/www.dynamed.com\/condition\/papillary-thyroid-cancer. Accessed August 2, 2020."},{"key":"10.4158\/ACCR-2019-0551_bb0035","first-page":"374","article-title":"New developments in the diagnosis and treatment of thyroid cancer","volume":"63","author":"Schneider","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"suppl 2","key":"10.4158\/ACCR-2019-0551_bb0040","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3816\/CLC.2004.s.003","article-title":"Pharmacology and mechanism of action of pemetrexed","volume":"5","author":"Adjei","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"10.4158\/ACCR-2019-0551_bb0045","first-page":"235","article-title":"VEGF Trapon inhibits tumor growth in papillary thyroid carcinoma","volume":"19","author":"Peng","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052030609X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052030609X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:34Z","timestamp":1762497094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S237606052030609X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S237606052030609X"],"URL":"https:\/\/doi.org\/10.4158\/accr-2019-0551","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradication of Papillary Thyroid Carcinoma In A Patient Receiving Pemetrexed and Bevacizumab","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/ACCR-2019-0551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}